Connect with us

BIOTECH

EVIO Inc (OTCMKTS:EVIO) Reports The Appointment of New President

Published

on

EVIO Inc (OTCMKTS:EVIO) reported the appointment of Mr. Al Lustig as President of company, reporting to CEO William Waldrop. Lustig’s major responsibility will be to lead company’s growth in both existing and new markets by executing and developing national and international operational strategies and sales.

The buzz

Lustig joins EVIO post completing a successful career at Pfizer Inc (NYSE:PFE). Lustig joined Pfizer as a Professional Sales Representative in in 1986 and later quickly ascended to roles of increased responsibility, becoming a State Director. During his role at Pfizer, Lustig led, helped and built manage several regional, national and district sales firms that consistently surpassed all performance outlooks.

Lustig redefined conventional business models that led in the successful launches of innovative and new pharmaceuticals, generating billions in sales and enhancing the lives of many patients. While at Pfizer, he even led several cross functional teams and associated with senior leadership to support integrate Sales, Operations, Strategy & Analytics, Government, Marketing and Medical Relations across business operations.

Waldrop, the CEO of EVIO, reported that as they embark upon their next phase of fast growth, Al’s history of known success in sales leadership and corporate growth at Pfizer, one of the largest bio-pharmaceutical firms across the world, makes him an ideal fit to help direct EVIO into 2018 and beyond. They look forward to using Al’s expertise and leadership from the pharmaceutical segment. Current EVIO Chief Operating Officer and President Lori Glauser has resigned from her role as President to pave way for Lustig in the Senior Leadership team. Glauser will remain with the firm as Chief Operating Officer, heading both company’s laboratory expansion and advisory services division.

In the last trading session, the stock price of EVIO jumped more than 10% to close the day at $2.16. The gains came at a share volume of 176,030 compared to average share volume of 141,794.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of MMJReporter.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS
Advertisement

Symbol        Alert        High        Gain

 

  VBIO          $0.67       $4.10      500%

  IMLFF        $0.11       $0.57      400%

  CMXC        $0.25       $0.45      80%

  REPCF       $0.54       $0.79      48%

 

Get Your Latest Winner Delivered to Your Inbox!

FREE

For The Next 48 Hours

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement